Bandingkan Harga & Kinerja Indofood CBP Sukses Makmur Tbk. (ICBP) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indofood CBP Sukses Makmur Tbk. dan Tempo Scan Pacific Tbk.: Indofood CBP Sukses Makmur Tbk. diperdagangkan di Rp7.550 (kapitalisasi pasar 88,05 T), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.790 (kapitalisasi pasar 12,58 T). Perbedaan utamanya: Indofood CBP Sukses Makmur Tbk. jauh lebih besar — sekitar 7× kapitalisasi pasar Tempo Scan Pacific Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| ICBP | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 88,05 T | 12,58 T |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indofood CBP Sukses Makmur Tbk.
PT Indofood CBP Sukses Makmur (the company) was established on Sept 2, 2009, based on Notarial Deed No.25 of Herdimansyah Chaidirsyah, S.H. The Company’s Articles of Association was amended several times, the latest of which was covered in the Notarial Deed no.28 of Benny Kristianto dated Jun 10, 2010, among other, for the amendments in the company's whole articles of Association to comply with the requirements of the Capital Market and Financial Institutions Supervisory Agency.The Company was a spin-off of the noodle division and food ingredient division of PT Indofood Sukses Makmur Tbk, the shareholder of the Company, and started to carry out the related business operations on Oct 1, 2009.
Selengkapnya di halaman ICBP →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
